INVega Is Studied In an Observational Design in the Netherlands.
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2014
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms INVISION
- Sponsors Janssen-Cilag
- 31 Aug 2018 Biomarkers information updated
- 06 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Planned number of patients changed from 250 to 27 as reported by ClinicalTrials.gov.